Tailored Menopausal Hormone Therapy for Gynecologic Cancer Survivors Key Insights and Care Strategies

Menopause brings significant changes to a woman’s body, and for gynecologic cancer survivors, these changes can be even more complex. The FIGO Committee recently released a position paper addressing menopausal hormone therapy (MHT) and postmenopausal care specifically for this group. Their findings highlight the importance of personalized care that balances benefits and risks while supporting survivors’ quality of life. This post explores the key insights from the paper and offers practical strategies for healthcare providers and survivors alike.

Want to read more?

Subscribe to obgynlibrary.com to keep reading this exclusive post.

Subscribe Now